NCT07201064View on ClinicalTrials.gov

A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

March 30, 2027

Study Completion Date

September 30, 2027

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG

SZ1003 injection

once every two weeks at a dose of SZ1003 injection per infusion.

All Listed Sponsors

lead

Guangdong ProCapZoom Biosciences Co., Ltd.

INDUSTRY